Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | PLAU | P00749 | 1/20 | 0.40 |
| ▸ | CD69 | Q07108 | 3/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1937755 | 0.75 | KMT2A (0.57) | ALOX15KMT2ACD69KDM4EPTPN7 | |
| SCHEMBL6045418 | 0.75 | ALOX15 (0.54) | ALOX15KMT2ACD69MCL1PTPN7 | |
| SCHEMBL11576418 | 0.74 | PLAU (0.64) | ALOX15KMT2APLAUMCL1KDM4E | |
| SCHEMBL13367355 | 0.69 | PTGS2 (0.59) | KMT2AKDM4ETDP1MEN1LMNA | |
| SCHEMBL341847 | 0.67 | ALOX15 (0.65) | ALOX15KMT2APTPN7MEN1 | |
| SCHEMBL2777170 | 0.66 | CA12 (0.52) | ALOX15PLAUKDM4ETDP1LMNA | |
| SCHEMBL28645298 | 0.66 | ALOX15 (0.65) | ALOX15KMT2ACD69MCL1PTPN7 | |
| SCHEMBL10167730 | 0.65 | NR4A2 (0.65) | ALOX15KMT2APTPN7LMNA | |
| SCHEMBL6566253 | 0.64 | PTPN7 (0.69) | ALOX15KMT2AMCL1KDM4EPTPN7 | |
| SCHEMBL8908528 | 0.64 | FOLH1 (0.37) | ALOX15KMT2AKDM4ETDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7928222-B2 | Porphyrin compound, process for producing porphyrin compound, three-dimensional optical recording material, and three-dimensional optical recording medium | National University Corporation NARA Institute of Science and Technology (JP) | 2011-04-19 | — | — | US | disclosed |
| US-20070224529-A1 | Porphyrin compound, process for producing porphyrin compound, three-dimensional optical recording material, and three-dimensional optical recording medium | National University Corporation NARA Institute of Science and Technology (JP) | 2007-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070224529-A1 | Porphyrin compound, process for producing porphyrin compound, three-dimensional optical recording material, and three-dimensional optical recording medium | PPOX, PNMT, PAH | ALOX15 1085/4885KMT2A 1471/4885PLAU 2766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.